G. Larrieu

724 total citations
33 papers, 633 citations indexed

About

G. Larrieu is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, G. Larrieu has authored 33 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in G. Larrieu's work include Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (11 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). G. Larrieu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (11 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). G. Larrieu collaborates with scholars based in France, Morocco and Switzerland. G. Larrieu's co-authors include P. Galtier, M. Alvinerie, C. Eeckhoutte, Jacques Dupuy, P. Lesca, J.F. Sutra, Anne Lespine, L.A.P. Hoogenboom, Thierry Pineau and Patrick Maurel and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

G. Larrieu

31 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Larrieu France 15 285 194 175 157 77 33 633
C. Eeckhoutte France 18 237 0.8× 255 1.3× 169 1.0× 154 1.0× 101 1.3× 36 665
E. Thorpe United Kingdom 18 208 0.7× 207 1.1× 82 0.5× 160 1.0× 133 1.7× 38 881
Philip B. Inskeep United States 18 63 0.2× 59 0.3× 61 0.3× 294 1.9× 78 1.0× 28 841
M. Carletti Italy 9 125 0.4× 76 0.4× 64 0.4× 102 0.6× 20 0.3× 21 364
Myriam Coulet Switzerland 13 71 0.2× 39 0.2× 49 0.3× 101 0.6× 94 1.2× 20 551
Ahmad Mirfazaelian Iran 10 77 0.3× 53 0.3× 39 0.2× 25 0.2× 100 1.3× 16 320
Gary O. Korsrud Canada 15 113 0.4× 52 0.3× 43 0.2× 121 0.8× 70 0.9× 42 720
Theodore M. Färber United States 12 125 0.4× 39 0.2× 51 0.3× 164 1.0× 48 0.6× 27 672
R.F.M. Maas Netherlands 13 107 0.4× 34 0.2× 23 0.1× 211 1.3× 369 4.8× 21 695
Naglaa M. El-Lakkany Egypt 21 215 0.8× 162 0.8× 29 0.2× 153 1.0× 104 1.4× 49 947

Countries citing papers authored by G. Larrieu

Since Specialization
Citations

This map shows the geographic impact of G. Larrieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Larrieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Larrieu more than expected).

Fields of papers citing papers by G. Larrieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Larrieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Larrieu. The network helps show where G. Larrieu may publish in the future.

Co-authorship network of co-authors of G. Larrieu

This figure shows the co-authorship network connecting the top 25 collaborators of G. Larrieu. A scholar is included among the top collaborators of G. Larrieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Larrieu. G. Larrieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dupuy, Jacques, G. Larrieu, J.F. Sutra, Anne Lespine, & M. Alvinerie. (2003). Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Veterinary Parasitology. 112(4). 337–347. 117 indexed citations
2.
Dupuy, Jacques, G. Larrieu, J.F. Sutra, C. Eeckhoutte, & M. Alvinerie. (2001). Influence of verapamil on the efflux and metabolism of 14C moxidectin in cultured rat hepatocytes. Journal of Veterinary Pharmacology and Therapeutics. 24(3). 171–177. 17 indexed citations
3.
Coulet, Myriam, C. Eeckhoutte, G. Larrieu, et al.. (2000). Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells. Chemico-Biological Interactions. 127(2). 109–124. 17 indexed citations
6.
Coulet, Myriam, Mauro Dacasto, C. Eeckhoutte, et al.. (1998). Identification of human and rabbit cytochromes P450 1A2 as major isoforms involved in thiabendazole 5‐hydroxylation. Fundamental and Clinical Pharmacology. 12(2). 225–235. 22 indexed citations
7.
Calleja, Cécile, C. Eeckhoutte, G. Larrieu, et al.. (1997). Differential Effects of Interleukin-1β, Interleukin-2, and Interferon-γ on the Inducible Expression of CYP 1A1 and CYP 1A2 in Cultured Rabbit Hepatocytes. Biochemical and Biophysical Research Communications. 239(1). 273–278. 22 indexed citations
8.
Guerre, Philippe, et al.. (1996). Dose-related effect of aflatoxin B1 on liver drug metabolizing enzymes in rabbit. Toxicology. 108(1-2). 39–48. 20 indexed citations
10.
Lesca, P., G. Larrieu, M. Alvinerie, et al.. (1995). Evidence for the Ligand-Independent Activation of the AH Receptor. Biochemical and Biophysical Research Communications. 209(2). 474–482. 75 indexed citations
11.
Larrieu, G., et al.. (1994). Thiabendazole Is an Inducer of Cytochrome P4501A1 in Cultured Rabbit Hepatocytes. Biochemical and Biophysical Research Communications. 202(3). 1483–1489. 56 indexed citations
12.
Larrieu, G., et al.. (1991). Comparison of mucosal drug conjugative rates along the gastrointestinal tract of female sheep. Journal of Veterinary Pharmacology and Therapeutics. 14(3). 263–268. 3 indexed citations
13.
Galtier, Pierre, Yves Vandenberghe, Sandra Coecke, et al.. (1991). Differential inhibition of rat hepatic glutathione S-transferase isoenzymes in the course of fascioliasis. Molecular and Biochemical Parasitology. 44(2). 255–260. 10 indexed citations
14.
Larrieu, G., et al.. (1990). Comparison of hepatic drug metabolizing enzymes in three-month-old lambs and kids. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 96(1). 111–114. 3 indexed citations
15.
Galtier, P., et al.. (1990). The development of drug‐metabolizing enzymes in female sheep livers. Journal of Veterinary Pharmacology and Therapeutics. 13(4). 340–349. 22 indexed citations
16.
Eeckhoutte, C., et al.. (1989). Comparative effects of T-2 toxin and diacetoxyscirpenol on drug metabolizing enzymes in rat tissues. Food and Chemical Toxicology. 27(4). 215–220. 24 indexed citations
17.
Larrieu, G. & P. Galtier. (1988). A comparative study of some oxidative and conjugative drug metabolizing enzymes in liver, lung and kidney of sheep. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 89(2). 225–228. 7 indexed citations
18.
Galtier, P., et al.. (1986). Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver.. PubMed. 14(1). 137–41. 70 indexed citations
19.
Galtier, P., G. Larrieu, & P. Lesca. (1985). Induction of drug metabolizing enzymes in the liver of rats infested withFasciola hepatica. Journal of Pharmacy and Pharmacology. 37(10). 751–754. 14 indexed citations
20.
Toutain, Pierre‐Louis, et al.. (1985). An in vivo model for pharmacokinetic studies in the kidney. Journal of Pharmacological Methods. 14(1). 1–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026